DatAIMed raises €1.2M from Maggioli Group for clinical AI platform expansion. The Turin-based startup strengthens its evidence-based healthcare knowledge system.
Amount Raised
€1.2 Million
Round Type
Seed
TurinBiotechnologyHealth CareArtificial IntelligenceInvestors
Description
DatAIMed, a Turin-based clinical AI startup, has secured €1.2 million in funding through a capital increase from Maggioli Group, which acquired a 20% stake in the company. The platform provides European healthcare professionals with evidence-based artificial intelligence for clinical knowledge and continuing medical education. DatAIMed's system allows natural language queries and returns concise summaries linked to verifiable sources from international biomedical literature and institutional references. The funding will support the expansion of the platform's adoption across European healthcare systems.
Who to call at DatAIMed, and when
A new round usually means DatAIMed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day DatAIMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at DatAIMed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at DatAIMed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment DatAIMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
DatAIMed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.